DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Bupivacaine Hydrochloride And Epinephrine is a drug marketed by Hospira and Septodont and is included in nine NDAs.
The generic ingredient in BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE is bupivacaine hydrochloride; epinephrine bitartrate. There are twelve drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the bupivacaine hydrochloride; epinephrine bitartrate profile page.
Recent Clinical Trials for BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE
Identify potential brand extensions & 505(b)(2) entrants
|St. Joseph's Healthcare Hamilton||Phase 2|
|Columbia University||Phase 4|
|University of Pennsylvania||Phase 4|